A new class of reagents for directly accessing more drug like molecules at the early stages of drug development will be developed. This technology is based on a new method to easily prepare saturated N-heterocycles, which have pro...
ver más
¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video
Fecha límite de participación
Sin fecha límite de participación.
Descripción del proyecto
A new class of reagents for directly accessing more drug like molecules at the early stages of drug development will be developed. This technology is based on a new method to easily prepare saturated N-heterocycles, which have proven advantages in drug like molecules but are difficult to prepare at the early stages of lead discovery and optimization. The key reactions and reagent has been validated and partners for distribution and test marketing established. The ERC PoC funding will support a first delivery of the reagents and support the development of new reagent classes in consultation with key industry leaders.